Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Gene Variations Can Predict Radiation-Induced Toxicity Risk

By BiotechDaily International staff writers
Posted on 04 Aug 2014
Key genetic variants may affect how cancer patients respond to radiation treatments, according to new research. Scientists discovered that differences in the TANC1 (tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1) gene are associated with a greater risk for radiation-fueled side effects in prostate cancer patients, which include impotence, diarrhea, and incontinence.

These findings, published July 2014 in Nature Genetics, are based on a genome-wide association study, a type of study in which researchers studied a variety of genetic variants to see if any of them are tied to a specific type of complication, which could sometimes appear years after treatment was completed.

“Our findings, which were replicated in two additional patient groups, represent a significant step towards developing personalized treatment plans for prostate cancer patients,” said Barry S. Rosenstein, PhD, professor, radiation oncology, genetics and genomic sciences, Icahn School of Medicine at Mount Sinai (New York, NY, USA), the lead Mount Sinai investigator on the study. “Within five years, through the use of a predictive genomic test that will be created using the data obtained in the recent study, it may be possible to optimize treatment for a large number of cancer patients.”

For the study, Dr. Rosenstein and his colleagues obtained blood samples from nearly 400 patients who were receiving radiotherapy treatment for prostate cancer. The blood samples were screened for roughly one million genetic markers, and each patient was monitored for at least two years to monitor incidents of side effects from the radiation. Data analysis revealed which genetic markers were consistently associated with the development of complications following radiotherapy.

“The next step is to validate the results, and see if the same markers predict similar outcomes in patients with other forms of cancer,” said Dr. Rosenstein. Using the genomic test being developed, treatment plans can be adjusted to curtail adverse effects thereby allowing for an improved quality life for many cancer survivors.

Related Links:

Icahn School of Medicine at Mount Sinai



Channels

Genomics/Proteomics

view channel
Image: Transmission electron micrograph of norovirus particles in feces (Photo courtesy of Wikimedia Commons).

Norovirus Interacts with Gut Bacteria to Establish a Persistent Infection That Can Be Blocked by Interferon Lambda

A team of molecular microbiologists and virologists has found that norovirus requires an intimate interaction with certain gut bacteria to establish a persistent infection, and that the infective process... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Lab Technologies

view channel
Image: MIT researchers have designed a microfluidic device that allows them to precisely trap pairs of cells (one red, one green) and observe how they interact over time (Photo courtesy of Burak Dura, MIT).

New Device Designed to See Communication between Immune Cells

The immune system is a complicated network of many different cells working together to defend against invaders. Effectively combating an infection depends on the interactions between these cells.... Read more

Business

view channel

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market. Powered by Intel Xeon processors, Dedicated Computing is providing a range of... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.